QT
VIR icon

Quantbot Technologies’s Vir Biotechnology VIR Stock Holding History

Quantbot Technologies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.71K Buy
+168
New +$1.6K ﹤0.01% 1880
2025
Q4 		– Sell
-14,620
Closed -$83.5K – 2206
2025
Q3 		$83.5K Hold
14,620
– – ﹤0.01% 1455
2025
Q2 		$73.7K Hold
14,620
– – ﹤0.01% 1449
2025
Q1 		$94.7K Hold
14,620
– – ﹤0.01% 1251
2024
Q4 		$107K Sell
14,620
-3,832
-21% -$30.2K ﹤0.01% 1186
2024
Q3 		$138K Buy
+18,452
New +$160K 0.01% 1109
2024
Q1 		– Sell
-4,600
Closed -$46.3K – 1981
2023
Q4 		$46.3K Buy
+4,600
New +$42K ﹤0.01% 1347
2022
Q2 		– Sell
-2,493
Closed -$64K – 2164
2022
Q1 		$64K Buy
+2,493
New +$73.9K 0.01% 1145
2021
Q2 		– Sell
-700
Closed -$35K – 1893
2021
Q1 		$35K Buy
700
+500
+250% +$26.9K ﹤0.01% 1085
2020
Q4 		$5K Sell
200
-700
-78% -$22.8K ﹤0.01% 1166
2020
Q3 		$30K Buy
+900
New +$38.7K ﹤0.01% 954

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Quantbot Technologies's VIR Position: Q2 2026 in Review

Quantbot Technologies opened a new position in Vir Biotechnology (VIR) in Q2 2026: 168 shares worth $1.71K. The stake represents ﹤0.01% of the portfolio and ranks #1880 among its holdings. This is a return to the name: Quantbot Technologies previously reported a position in VIR as recently as Q3 2025.

Quantbot Technologies first reported a position in VIR in Q3 2020 and has held it in 11 quarters since. The position peaked at $138K in Q3 2024. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Quantbot Technologies held 168 shares of Vir Biotechnology worth $1.71K as of Q2 2026.
  • Vir Biotechnology was a new Quantbot Technologies position in Q2 2026.
  • Vir Biotechnology made up ﹤0.01% of Quantbot Technologies's portfolio in Q2 2026, its #1880 holding.
  • Quantbot Technologies first reported a position in Vir Biotechnology in Q3 2020 and has held it in 11 quarters since.
  • Quantbot Technologies's Vir Biotechnology position peaked at $138K in Q3 2024.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Quantbot Technologies's 13F filing for Q2 2026, filed 12 Aug 2026.